Top Markets
#1 Siren Siren +33.48%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.74%
#3 Wiki Cat Wiki Cat +19.10%
#4 TRIA TRIA +18.46%
#5 Nockchain Nockchain +18.17%
#6 Ribbita by Virtuals Ribbita by Virtuals +17.65%
#7 PulseChain PulseChain +16.92%
#8 Velvet Velvet +16.25%
#9 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.91%
#10 Bitway Bitway +15.30%
Coin of the day
Siren Siren
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Skye Bioscience, Inc. Skye Bioscience, Inc.

Skye Bioscience, Inc.

SKYE
Rang in Aktien #31384
Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on... Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.
Aktienkurs
$0.3799
Marktkapitalisierung
$13.35M
Veränderung (1 Tag)
-8.48%
Veränderung (1 Jahr)
-88.79%
Land
US
Handel Skye Bioscience, Inc. (SKYE)

Kategorie

Healthcare
Dividendenhistorie für Skye Bioscience, Inc. (SKYE)
Skye Bioscience, Inc. (Aktienkürzel: SKYE) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für Skye Bioscience, Inc. (SKYE) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Dividendenzahlungen Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
29.00%
BE